Exelixis stumbles after cancer drug candidate fails second phase 3 clinical trial

December 1, 2014 7:57 PM

12 0

Proactive Investors North America Inc, trades as "Proactiveinvestors USA & Canada".

You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or th...

Read more

To category page